Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

NCT04192591 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04192591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 30, 2020
Completion date
February 28, 2041
Enrollment
166 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar spinal stenosis